Regulators

Global regulatory updates

Follow FDA, EMA, PMDA, MHRA, and other agencies across approvals, warnings, inspections, guidance, and drug policy signals.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

News

Pharma News

Daily pharmaceutical, biotech, medtech, and research coverage designed for search and discovery.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Coverage

Latest indexed stories

90 stories in the current hub snapshot

🇧🇷11h agoRegulatoryinterfarma.org.br

Featured signal

Após 30 anos, a Lei de Propriedade Industrial precisa evoluir, afirma presidente da Interfarma

Publisher

Interfarma Brazil

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Interfarma Brazil· Original publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍11h agoRegulatoryeof.gr

EU Innovation Network (EU IN)

EOF Greece· Original source

🇪🇸16h agoRegulatoryaemps.gob.es

La AEMPS informa del cese de comercialización, retirada del mercado y recuperación de un lote del producto cosmético Suavinex Baby Cologne Memories

AEMPS (Spain)· Original source

🌍18h agoRegulatoryeof.gr

Γενόσημα Ιανουαρίου 2026_Τελικές Προτεινόμενες Τιμές

EOF Greece· Original source

🇬🇧3d agoRegulatorygov.uk

Field Safety Notices: 1 May 2026

MHRA UK· Original source

🇬🇧3d agoRegulatorygov.uk

Decision: Medical devices given exceptional use authorisations

MHRA UK· Original source

🇯🇵3d agoRegulatorypmda.go.jp

[KOKUSAI]PMDA-ATC Learning videos have been updated

PMDA Japan· Original source

🇬🇧4d agoRegulatorygov.uk

Field Safety Notices: 20 to 24 April 2026

MHRA UK· Original source

🇬🇧4d agoRegulatorygov.uk

Decision: Orphan registered medicinal products

MHRA UK· Original source

🇬🇧4d agoRegulatorygov.uk

Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse

MHRA UK· Original source

🌍4d agoRegulatoryeof.gr

“DIAFORM RX”

EOF Greece· Original source

🇬🇧4d agoRegulatorygov.uk

Guidance: The Innovative Devices Access Pathway (IDAP)

MHRA UK· Original source

🌍4d agoRegulatorynafdac.gov.ng

Public Alert No. 024/2026 – Alert on Counterfeit Augmentin 625mg Tablets (Batch No. AC3N) in Nigeria

NAFDAC Nigeria· Original source

🌍4d agoRegulatoryifpma.org

Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

IFPMA Global· Original source

🌍5d agoRegulatorynafdac.gov.ng

Note to Industry on Requirement for Bioequivalence Study

NAFDAC Nigeria· Original source

🇧🇷5d agoRegulatoryinterfarma.org.br

Interfarma na Imprensa: Interfarma ressalta importância de previsibilidade regulatória após adiamento da Resolução CMED nº 3/2025

Interfarma Brazil· Original source

🇧🇷5d agoRegulatoryinterfarma.org.br

Interfarma destaca papel do acesso sustentável à inovação na edição especial do Global Forum 2026

Interfarma Brazil· Original source

🇧🇷5d agoRegulatoryinterfarma.org.br

Acompanhe o Summit Propriedade Intelectual na Agenda Pública

Interfarma Brazil· Original source

🌍5d agoRegulatoryacrpnet.org

Defining Leadership for Oneself is Key to Becoming a Leader, ACRP 2026 Panelists Say

ACRP Association· Original source

🇬🇧5d agoRegulatoryabpi.org.uk

ABPI celebrates a month of major investment commitments into UK life sciences

ABPI UK· Original source

🌍5d agoRegulatoryacrpnet.org

Attendees Encouraged to “Act with Courage, Driven by Purpose” as ACRP 2026 Closes

ACRP Association· Original source

🇪🇸5d agoRegulatoryaemps.gob.es

La AEMPS informa del cese de comercialización y la retirada del mercado de Deliplus Men Depil bajo la ducha

AEMPS (Spain)· Original source

🇧🇷5d agoRegulatoryinterfarma.org.br

Prorrogação da entrada em vigor da Resolução CMED nº 3/2025 é positiva, avalia Interfarma

Interfarma Brazil· Original source

🇬🇧5d agoRegulatorygov.uk

MHRA Safety Roundup: April 2026

MHRA UK· Original source

🇬🇧5d agoRegulatorygov.uk

Good laboratory practice (GLP) for safety tests on chemicals

MHRA UK· Original source

🌍5d agoRegulatoryargentina.gob.ar

ANMAT cancela la habilitación de la firma REHUE S.A. y prohíbe la comercialización de sus productos

ANMAT Noticias· Original source

🌍5d agoRegulatoryargentina.gob.ar

ANMAT suspendió el certificado de buenas prácticas de la firma ELECTRON PLAST S.A. y prohibió la comercialización de productos de terceros con destino a tránsito interjurisdiccional

ANMAT Noticias· Original source

🌍5d agoRegulatoryeof.gr

Ανακοίνωση σχετικά με την Ευρωπαϊκή Βάση Δεδομένων Ι/Π- EUDAMED

EOF Greece· Original source

🌍5d agoRegulatoryeof.gr

Aπαγόρευση διάθεσης και διακίνησης των προϊόντων

EOF Greece· Original source

🌍5d agoRegulatoryeof.gr

Eκτέλεση προϋπολογισμού μηνός Μαρτίου 2026

EOF Greece· Original source

🇪🇸5d agoRegulatoryaemps.gob.es

La AEMPS adecúa los formatos de antibióticos para alinearlos con las pautas clínicas habituales y evitar su uso inapropiado

AEMPS (Spain)· Original source

🇪🇸5d agoRegulatoryaemps.gob.es

Boletín sobre Cosméticos, Biocidas AEMPS y Productos de Cuidado Personal. Enero-marzo 2026

AEMPS (Spain)· Original source

🇸🇬5d agoRegulatoryapacmed.org

Across the Codes: Navigating MedTech Compliance Expectations in the Region

APACMed· Original source

🌍5d agoRegulatorypharmac.govt.nz

Wegovy and Mounjaro for weight loss not funded

Pharmac New Zealand· Original source

🇬🇧6d agoRegulatorygov.uk

Clinical investigations for medical devices

MHRA UK· Original source

🇬🇧6d agoRegulatorygov.uk

Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22

MHRA UK· Original source

🌍6d agoRegulatoryeof.gr

Γενόσημα Μαρτίου 2026 _ Προτεινόμενες Τιμές προς Διαβούλευση

EOF Greece· Original source

🌍6d agoRegulatoryeof.gr

Ανάκληση των παρτίδων του συνημμένου πίνακα του Ιατροτεχνολογικου προϊόντος, MDD Class IIΙ, 16F Dual—Valved Splittable Sheath Introducer

EOF Greece· Original source

🇬🇧6d agoRegulatorygov.uk

Transparency data: MHRA Performance Data

MHRA UK· Original source

🇬🇧6d agoRegulatorygov.uk

Corporate report: MHRA Results and Forecast 2025/26; 2026/27

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Clinical trials for medicines: good manufacturing practice and radiopharmaceutical investigational medicinal products

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Clinical trials for medicines: non-investigational medicinal products

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Guidance: Clinical Trials Regulations enforcement provisions

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Guidance: Clinical trials for medicines: roles and responsibilities

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Guidance: Clinical trials for medicines: Archiving and retention of clinical trial records

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Clinical trials for medicines: notifiable trials

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Clinical trials for medicines: labelling

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Clinical trials for medicines: Good clinical practice inspections

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Guidance: Clinical trials for medicines: International Council for Harmonisation (ICH) annotations

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Guidance: Clinical trials for medicines: Notification of Serious Breaches of GCP or the trial protocol

MHRA UK· Original source

🇬🇧Apr 28Regulatorygov.uk

Guidance: Clinical trials for medicines: Declaration of Helsinki and Clinical Trial Regulations alignment

MHRA UK· Original source

🌍Apr 28Regulatorymyscrs.org

Leading the Cut: 4 Organizations Take on Site Training Reduction

SCRS (Clinical Research Sites)· Original source

🌍Apr 28Regulatorybioworld.com

US legislative reforms needed to make biosimilars competitive

BioWorld Regulatory RSS· Original source

🌍Apr 27Regulatoryeof.gr

Νέα ΣΥΦΑ 1ου Τριμήνου 2026 _ Τιμολόγηση Φαρμακευτικών Προϊόντων

EOF Greece· Original source

🇪🇸Apr 27Regulatoryaemps.gob.es

Boletín sobre Productos Sanitarios. Enero-marzo 2026

AEMPS (Spain)· Original source

🌍Apr 27Regulatoryacrpnet.org

ACRP 2026 Panelists Encourage Attendees to “Embrace the Now, Ignite What’s Next”

ACRP Association· Original source

🌍Apr 27Regulatoryinfarma.pl

KOMENTARZ z okazji Światowego Dnia Własności Intelektualnej. prof. Rafał Sikorski, Uniwersytet im. Adama Mickiewicza w Poznaniu

INFARMA Poland· Original source

🌍Apr 27Regulatoryeof.gr

Γενόσημα Φεβρουάριος 2026 _ Προτεινόμενες Τιμές προς Διαβούλευση

EOF Greece· Original source

🇪🇸Apr 27Regulatoryaemps.gob.es

La AEMPS informa del cese de comercialización, retirada del mercado y recuperación de la tinta para tatuaje Dynamic Candy Apple Red

AEMPS (Spain)· Original source

🇧🇪Apr 27Regulatoryfamhp.be

Attention aux confusions entre flacons

FAMHP Belgium· Original source

🇯🇵Apr 27Regulatorypmda.go.jp

[ANZEN]PMDA Medical Safety Information: Use of Insulin-Specific Syringe- Incorrect dose may cause serious adverse health effects- posted

PMDA Japan· Original source

🇯🇵Apr 27Regulatorypmda.go.jp

[YAKKYOKUKATA]Implementation of PDG harmonized texts into Japanese Pharmacopoeia (General Chapters) updated

PMDA Japan· Original source

🇯🇵Apr 27Regulatorypmda.go.jp

[YAKKYOKUKATA]Implementation of PDG harmonized texts into Japanese Pharmacopoeia (Monographs) updated

PMDA Japan· Original source

🇯🇵Apr 27Regulatorypmda.go.jp

[KOKUSAI]Information on PMDA Asia Office updated

PMDA Japan· Original source

🌍Apr 26Regulatoryacrpnet.org

“What Got Us Here, Won’t Get Us There,” and Other Insights on the Clinical Research Workforce Shared at ACRP 2026

ACRP Association· Original source

🌍Apr 25Regulatorycssp.gob.sv

Suspensión de Servicios

Consejo Superior de Salud Pública (El Salvador)· Original source

🌍Apr 25Regulatoryargentina.gob.ar

ANMAT facilita la importación de productos necesarios para el desarrollo de estudios clínicos

ANMAT Noticias· Original source

🌍Apr 25Regulatorymyscrs.org

Behind the Budget: What Sites Really Need to Know Today

SCRS (Clinical Research Sites)· Original source

🌍Apr 25Regulatorymyscrs.org

Why Site Support Goes Unused in Clinical Trials

SCRS (Clinical Research Sites)· Original source

🌍Apr 25Regulatorymyscrs.org

Mobility in Clinical Trial Operations with the SIP Mobile App: Practical Gains, New Friction Points, and What to Watch

SCRS (Clinical Research Sites)· Original source

🌍Apr 25Regulatorymyscrs.org

Cardiometabolic Trials are Exposing a Flaw in the Clinical Research Model: Retention is Engineered Upstream

SCRS (Clinical Research Sites)· Original source

🌍Apr 25Regulatorymyscrs.org

Bridging Innovation and Reality: Why Human Support Is Essential in Tech-Enabled Clinical Trials

SCRS (Clinical Research Sites)· Original source

🇪🇸Apr 24Regulatoryaemps.gob.es

La AEMPS informa de un posible error de software en las versiones 1.5 a 1.6 de la aplicación Dexcom One+ iOS

AEMPS (Spain)· Original source

🌍Apr 24Regulatorybioworld.com

A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

BioWorld Regulatory RSS· Original source

🌍Apr 24Regulatorybioworld.com

FDA, CMS partner to deliver RAPIDly for innovative devices

BioWorld Regulatory RSS· Original source

🌍Apr 23Regulatorycssp.gob.sv

El presidente del CSSP, Lic. Daniel Quinteros, junto con equipo técnico realiza visita a el Instituto Especializado Hospital El Salvador (IEHES)

Consejo Superior de Salud Pública (El Salvador)· Original source

🇪🇸Apr 23Regulatoryaemps.gob.es

La AEMPS informa de un posible error en las versiones 2.9.0 a 2.11.2 de las aplicaciones Dexcom G7 iOS y Dexcom G7 Watch iOS

AEMPS (Spain)· Original source

🇪🇸Apr 23Regulatoryaemps.gob.es

La AEMPS informa del cese de comercialización, retirada del mercado y recuperación de los cosméticos Blonde Henna y Oil Balance, de la marca Real Earth

AEMPS (Spain)· Original source

🇪🇸Apr 23Regulatoryaemps.gob.es

Boletín sobre Seguridad de Medicamentos de Uso Humano. Febrero de 2026

AEMPS (Spain)· Original source

🇧🇪Apr 23Regulatoryfamhp.be

Webinaires EUDAMED : formation aux modules Acteurs, UDI/Dispositifs et Organismes notifiés/Certificats

FAMHP Belgium· Original source

🌍Apr 23Regulatorypharmac.govt.nz

Agenda for May 2026 Immunisation Advisory Committee (IAC) meeting

Pharmac New Zealand· Original source

🌍Apr 23Regulatoryfifarma.org

Información Electrónica de Prescripción (ePI): Acelerando la Transformación Digital de los Sistemas de Salud en América Latina

FIFARMA News· Original source

🌍Apr 23Regulatorybioworld.com

CMS to Bridge coverage for obesity drugs as BALANCE teeters

BioWorld Regulatory RSS· Original source

🇪🇸Apr 22Regulatoryaemps.gob.es

La AEMPS informa del lanzamiento de un programa piloto de la EMA para impulsar el desarrollo de productos sanitarios y productos sanitarios in vitro innovadores

AEMPS (Spain)· Original source

🇪🇸Apr 22Regulatoryaemps.gob.es

La AEMPS informa de la detección de productos sanitarios falsos bajo las marcas GEBRO-Mesoceuticals y VANE-Mesoceuticals en el mercado europeo

AEMPS (Spain)· Original source

🌍Apr 22Regulatoryargentina.gob.ar

ANMAT suspende el certificado de BPF y prohíbe la comercialización de productos médicos de la firma RIPEZZI S.R.L.

ANMAT Noticias· Original source

🌍Apr 22Regulatoryargentina.gob.ar

ANMAT dispuso la suspensión de habilitaciones de la firma BIOGAMMA S.R.L.

ANMAT Noticias· Original source

🌍Apr 22Regulatorybioworld.com

Xuanzhu shares dip despite phase III ALK inhibitor data

BioWorld NMPA RSS· Original source

🌍Apr 22Regulatorybioworld.com

Biogen amasses full felzartamab rights with $850M TJ deal

BioWorld NMPA RSS· Original source